InMed Pharmaceuticals (INM) Revenue (2019 - 2026)
InMed Pharmaceuticals (INM) revenue from Sep 30, 2019 to Mar 31, 2026. The TTM InMed Pharmaceuticals (INM) revenue is $3.24M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
InMed Pharmaceuticals (INM) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -34.01% |
| 3 Years TTM | +7.47% |
| 5 Years TTM | +35.10% |
Annual Revenue change of InMed Pharmaceuticals (INM)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $0 | -100.00% |
| 2025 | $4.94M | +7.39% |
| 2024 | $4.60M | +235.77% |
| 2023 | $1.37M | N/A |
| 2022 | $1.37M | -27.89% |
| 2021 | $1.90M | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
Comparison InMed Pharmaceuticals (INM) five years revenue CAGR with competitors
InMed Pharmaceuticals (INM) five years revenue CAGR is 35.36%.